# Insulet Corp (PODD)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/insulet-corp/ JSON: https://steadybase.io/company/insulet-corp.json Checked Nov 10, 2026. Latest filing read: Nov 4, 2026.

## Company

- Legal name: INSULET CORP
- Ticker: PODD (Nasdaq)
- SEC CIK: 0001145197
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Acton, MA
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: insulet.com
- LinkedIn: https://www.linkedin.com/company/insulet-corporation
- Next earnings date: Feb 3, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $2.7B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 18, 2026). Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/0001145197-26-000028-index.html
- Operating income: $473.8M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 18, 2026). Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/0001145197-26-000028-index.html
- Net income: $247.1M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 18, 2026). Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/0001145197-26-000028-index.html
- SG&A: $1.2B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 18, 2026). Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/0001145197-26-000028-index.html
- Employees: 5,400 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- Shares outstanding: 69,371,043 as of Oct 27, 2026 (10-Q filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000192/0001145197-26-000192-index.html
- Auditor: Grant Thornton LLP, Boston, Massachusetts, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm

## Business

Insulet Corporation (“we” or the “Company”) is primarily engaged in the development, manufacture, and sale of its proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod platform includes: the Omnipod ® 5 Automated Insulin Delivery System (“Omnipod 5”), the Omnipod DASH ® Insulin Management System (“Omnipod DASH”), and the Omnipod Insulin Management System (“Classic Omnipod”).

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $2.7B | $473.8M | $247.1M | $1.2B |
| Dec 31, 2024 | $2.1B | $308.9M | $418.3M | $917.2M |
| Dec 31, 2023 | $1.7B | $220.1M | $206.3M | $734.8M |
| Dec 31, 2022 | $1.3B | $37.6M | $4.6M | $587.8M |
| Dec 31, 2021 | $1.1B | $126.0M | $16.8M | $466.0M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/insulet-corp.json

## Officers and directors

- Ashley McEvoy, President and CEO. Source: 8-K filed Nov 4, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000190/podd2026-09x30ex991.htm
- Flavia Pease, EVP & CFO. Source: Form 4 filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000059/0001145197-26-000059-index.htm
- Flavia H. Pease, Chief Financial Officer, Executive Vice President. LinkedIn: https://linkedin.com/in/flavia-pease-6038bbb. Source: 10-K filed Feb 18, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- Eric Benjamin, EVP and COO. LinkedIn: https://linkedin.com/in/eric-benjamin-insulet. Source: Form 4 filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000071/0001145197-26-000071-index.htm
- Lisa Blair Davis, SVP, Chief HR Officer. Source: Form 4 filed Aug 4, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000165/0001145197-26-000165-index.htm
- Michael Panos, EVP and CCO. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000093/0001145197-26-000093-index.htm
- John W. Kapples, SVP and General Counsel. Source: Form 4 filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000072/0001145197-26-000072-index.htm
- Lauren Budden, Group VP, CAO and Controller. Source: Form 4 filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000073/0001145197-26-000073-index.htm
- Jonathan J. Mazelsky, Class II director. Source: 8-K filed Jun 25, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000148/podd-20260624.htm
- Laetitia Cousin, SVP, Reg, Quality & Compliance. LinkedIn: https://linkedin.com/in/laetitia-cousin. Source: Form 4 filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000074/0001145197-26-000074-index.htm
- Prem Singh, SVP, Global Operations. LinkedIn: https://linkedin.com/in/prem-singh-2961b9b. Source: Form 4 filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000075/0001145197-26-000075-index.htm
- Elizabeth H. Weatherman, Director. Source: 10-K filed Feb 18, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- Jessica Hopfield, Director. Source: 10-K filed Feb 18, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- Luciana Borio, M.D., Director. Source: 10-K filed Feb 18, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- Robert L. Huffines, Director. Source: 10-K filed Feb 18, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- Timothy C. Stonesifer, Director. Source: 10-K filed Feb 18, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- Wayne A.I. Frederick, M.D., Director. Source: 10-K filed Feb 18, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- John Kapples, Named in proxy. Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114036126013333/ny20060552x1_def14a.htm
- Luciana Borio, Board member (per proxy). Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114036126013333/ny20060552x1_def14a.htm
- Michael H. Panos, Named in proxy. Source: DEF 14A filed Apr 6, 2026, https://www.sec.gov/Archives/edgar/data/1145197/000114036126013333/ny20060552x1_def14a.htm

## Recent 8-K events

- Nov 4, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000190/podd-20261104.htm
- Sep 21, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000119312526396779/d71204d8k.htm
- Sep 16, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000177/podd-20260914.htm
- Sep 10, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000175/podd-20260903.htm
- Aug 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000167/podd-20260805.htm
- Jun 25, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000148/podd-20260624.htm
- May 26, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000132/podd-20260526.htm
- May 21, 2026: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000121/podd-20260520.htm
- May 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000100/podd-20260506.htm
- Apr 29, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000095/podd-20260429.htm

## Insider trades (Form 4)

- Aug 21, 2026: Ashley McEvoy (President and CEO) bought 1,100 shares, about $162,217. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000172/0001145197-26-000172-index.htm
- Jun 3, 2026: Timothy C. Stonesifer (Director) bought 2,790 shares, about $400,393. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000143/0001145197-26-000143-index.htm
- Jun 3, 2026: Luciana Borio (Director) sold 418 shares, about $59,887. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000142/0001145197-26-000142-index.htm
- Jun 3, 2026: Elizabeth H. Weatherman (Director) bought 3,450 shares, about $497,490. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000138/0001145197-26-000138-index.htm
- Feb 25, 2026: Michael R. Minogue (Director) bought 2,030 shares, about $499,847. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000044/0001145197-26-000044-index.htm
- Feb 20, 2026: Ashley McEvoy (President and CEO) bought 4,300 shares, about $1.0M. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000031/0001145197-26-000031-index.htm
- Dec 15, 2025: Wayne A.I. Frederick (Director) sold 1,851 shares, about $542,510. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519725000074/0001145197-25-000074-index.htm
- Dec 5, 2025: Timothy C. Stonesifer (Director) bought 962 shares, about $299,884. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519725000072/0001145197-25-000072-index.htm
- Sep 8, 2025: Prem Singh (SVP, Global Operations) sold 687 shares, about $238,726. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519725000052/0001145197-25-000052-index.htm
- Sep 8, 2025: Laetitia Cousin (SVP, Reg, Quality & Compliance) sold 797 shares, about $278,002. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519725000051/0001145197-25-000051-index.htm
- Aug 21, 2025: Eric Benjamin (EVP, CPXO) sold 4,263 shares, about $1.4M. Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519725000048/0001145197-25-000048-index.htm
- Aug 7, 2025: Prem Singh (SVP, Global Operations) sold 1,343 shares, about $429,760. Source: https://www.sec.gov/Archives/edgar/data/1145197/000112760225020277/0001127602-25-020277-index.htm

## What management said

- "Our team delivered a strong quarter, with revenue growth of nearly 20% and significant margin expansion" Ashley McEvoy, President and CEO (8-K filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000190/podd2026-09x30ex991.htm

## Latest filings

- 8-K filed Sep 21, 2026: https://www.sec.gov/Archives/edgar/data/1145197/000119312526396779/d71204d8k.htm
- 10-K filed Feb 18, 2026: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/podd-20251231.htm
- 10-Q filed Aug 5, 2026: https://www.sec.gov/Archives/edgar/data/1145197/000114519726000169/podd-20260630.htm
- DEF 14A filed Apr 6, 2026: https://www.sec.gov/Archives/edgar/data/1145197/000114036126013333/ny20060552x1_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/